INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsMediumPositive
Announced Mon, 15 Dec · 18:33 IST

Receipt of Good Manufacturing Practice (GMP) certificate from National Center for Public Health and Pharmacy (NNGYK-Hungary).

Regulatory Product ApprovalBusiness Updates View source PDF

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Laboratories has received a Good Manufacturing Practice (GMP) certificate from Hungary's National Center for Public Health and Pharmacy (NNGYK). The certification validates that the company's manufacturing facilities meet European quality and compliance standards. This approval enables the company to manufacture and supply pharmaceutical products to Hungary and other European markets that accept this certification. The announcement does not disclose any specific financial impact, order value, or timeline for commercial supply.

Likely market impact

This is a positive development for Ind-Swift Laboratories as it strengthens its position in regulated European markets, potentially opening doors for new export revenue and partnerships. However, without disclosed order size or commercial timeline, the near-term stock impact may be limited.